Phase 1: Establishment of Drs and Co

Event: PMAD founders create Drs and Co

Details: A team consisting of physicians, scientists, and chemists come together to establish a brand known as Drs and Co. The focus is on developing highly efficacious and bioavailable products. Their primary goal is to offer alternatives to pain medication that are not only safer but more beneficial to the consumer.

Phase 2: Search for a Manufacturing Partner

Event: PMAD founders seek a manufacturing partner

Details: In line with their brand ethos, the founders start looking for a manufacturing facility that upholds their standards of quality and transparency. This partner must align with their commitment to superior product formulations.

Phase 3: Encountering Challenges

Event: Visiting multiple facilities

Details: After visiting five different manufacturing facilities and not finding one that meets their stringent criteria, the founders face a crucial decision point. The facilities visited lacked either the quality, structure, or transparency that Drs and Co. deemed essential.

Phase 4: Self-Funded Manufacturing Facility

Event: Decision to self-fund a facility

Details: PMAD founders choose to invest their resources into creating the first physician-backed manufacturing facility. The focus is to leverage their medical and scientific expertise to develop the most bioavailable formulations, prioritizing education and transparency at every step.

Phase 5: White Labeling Strategy

Event: Opening the facility for White Label services

Details: To influence the industry positively, the facility opens up for White Label services. This allows other brands to imbue their products with the same quality and educational value, helping to instill trust and elevate industry standards.

Phase 6: Emphasizing Transparency

Event: Focus on transparency

Details: PMAD founders reinforce the importance of transparency, ensuring that all aspects of extraction, formulation, and manufacturing are openly shared. This policy is not just for in-house products but also extends to all brands that partner with their manufacturing facility.

Phase 7: Pharmaceutical Approach

Event: Adopting pharmaceutical-grade manufacturing and formulation

Details: PMAD adopts a pharmaceutical approach to their operations, focusing on providing trustworthy and research-driven analytical data. This data encompasses lesser-known ingredients and formulations, including adaptogens, and exotic components, ensuring that the products are not just effective but are also backed by solid research.

Phase 8: Educational Emphasis

Event: Educating consumers through a selfless approach

Details: By educating consumers about the ingredients and processes used, PMAD empowers them with knowledge. This information allows consumers to understand why specific products are effective, enabling them to make informed choices and helping brands to grow by offering products that truly meet the needs of their specific demographics.

Phase 9: Ethos and Trust Building

Event: Cultivating trust between all stakeholders

Details: The multifaceted approach taken by PMAD is rooted in their original ethos. It seeks to establish trust among brands, consumers, and lawmakers. This trust is pivotal in providing a safe and enjoyable experience with products and encourages uninhibited growth and innovation in the industry.